Parenting and Family Support Centre, School of Psychology, The University of Queensland, Brisbane, Australia.
School of Nursing and Midwifery, Griffith University, Brisbane, Australia.
Clin Child Fam Psychol Rev. 2022 Jun;25(2):316-338. doi: 10.1007/s10567-021-00371-3. Epub 2021 Sep 27.
Considering the significant impact of perinatal depression on both maternal wellbeing and infant development, it is important to examine the effectiveness of interventions designed to prevent or reduce these risks. This systematic review and meta-analysis synthesised evidence on parenting intervention in relation to how such programs affect symptoms of perinatal depression and infant outcomes within 12 months of postpartum. We followed the Cochrane Collaboration guidelines on conducting systematic reviews and meta-analyses. A total of five electronic databases were searched for controlled trials that met pre-determined eligibility criteria. Outcomes of interest were maternal depressive symptoms and infants' language, motor and socioemotional development. Seventeen studies involving 1665 participants were included in the systematic review. Estimates from a random effects model of 15 studies in the final meta-analysis revealed statistically significant reductions in maternal depressive symptoms at post-intervention for mothers allocated to receive parenting interventions (SMD = - 0.34, 95%CI - 0.44, - 0.24; z = 5.97, p < 0.001; I = 0%). Data on infant development outcomes from the included studies were scarce, and therefore, infant outcomes were not analysed in this review. For individual study outcomes, the majority of studies reported a general trend for reductions in maternal depressive symptoms from pre- to post-intervention. Although parenting interventions are frequently considered preventive strategies that are designed to offer support to parents and impart skills that promote their physical and psychological wellbeing, our findings suggest that these interventions have a positive effect on perinatal depressive symptoms. Implications and recommendations for future research are addressed. The systematic review protocol was registered with PROSPERO 2020 CRD42020184491.
考虑到围产期抑郁对母婴健康和婴儿发育的重大影响,研究旨在预防或减少这些风险的干预措施的有效性是很重要的。本系统评价和荟萃分析综合了与育儿干预相关的证据,这些干预措施如何影响产后 12 个月内围产期抑郁的症状和婴儿的结局。我们遵循 Cochrane 协作组关于进行系统评价和荟萃分析的指南。共检索了 5 个电子数据库,以寻找符合预先确定的合格标准的对照试验。感兴趣的结果是母亲的抑郁症状和婴儿的语言、运动和社会情感发展。17 项研究共涉及 1665 名参与者被纳入系统评价。最终荟萃分析中 15 项研究的随机效应模型估计结果显示,接受育儿干预的母亲在干预后,其抑郁症状有统计学意义的降低(SMD=-0.34,95%CI-0.44,-0.24;z=5.97,p<0.001;I=0%)。纳入研究中关于婴儿发育结局的数据很少,因此本综述未对婴儿结局进行分析。对于个别研究结果,大多数研究报告了从干预前到干预后母亲抑郁症状普遍降低的趋势。尽管育儿干预通常被认为是预防策略,旨在为父母提供支持并传授促进其身心健康的技能,但我们的研究结果表明,这些干预措施对围产期抑郁症状有积极影响。本文还讨论了对未来研究的影响和建议。系统评价方案在 PROSPERO 2020 CRD42020184491 中注册。